Publisher's Synopsis
In 2020, the President of the United States of America made a claim that Hydroxychloroquine could be used as a treatment for Covid 19. The FDA authorized the emergency use of hydroxychloroquine in March 2020. A week later Donald Trump endorsed the drug as a potential Covid-19 treatment and the government stockpiled millions of doses. The President only made his statement after being briefed by the FDA that it was indeed a 'game changer'. The 'Left Wing' element of US politics and news, then quickly jumped on this statement to use this as a weapon against the former President. A study was released by infectious-disease researchers in New Jersey. The researchers studied 255 patients at Saint Barnabas Medical Center in Livingston, N.J., during the early months of the pandemic. They conclude that a combination of hydroxychloroquine and azithromycin at certain levels translates to "a survival rate 2.9 times the other patients." Trump himself recently released a list of things "they are now admitting I was right about" that included, with no qualification, "Hydroxychloroquine works." Hydroxychloroquine, the malaria drug touted as a "game changer" magical Covid-19 cure by former US President Donald Trump in 2020, has been found effective in a prophylactic study published in the Journal of The Association of Physicians of India. Hydroxychloroquine may have become politicized in the US but India uses it widely. "It's the politicization of this medicine by the mainstream media and portions of the medical community that somehow made this a battle between President (Donald) Trump and them, and created this undue fear and hysteria over a drug, a medicine that has been used for over 60 years relatively safely and is regularly prescribed to pregnant women if they are going to a malaria zone," White House Office of Trade and Manufacturing Policy Director Peter Navarro told reporters. "The idea that this is a dangerous drug is just silly, but if you ask the American people based on the media's coverage of it, that is kind of the state of play right now," he said. Navarro said four doctors at the Detroit Hospital System filed a request for emergency use authorization for hydroxychloroquine. The request was for three things; "One, for early treatment use in a hospital setting. Number two, treatment between a doctor and his patient in an outpatient setting. Three, not just as a therapeutic but also as a possible prophylaxis for preventative use," he said.
